RE: Investor relations20 Dec 2021 11:11
I think it's pretty obvious why shareholders are disgruntled at the moment and imo we have fair reason. Testing going crazy and we haven't had an operational update for nearly 3 months. Intrinsic value must be elevating nicely whilst the SP continues to be disconnected hugely.
I wouldn't expect ncyt to release an RNS saying "things are on track, sales are inline with previous announcement. Unfortunately, still nothing changed too much in US, government not approved any more tests yet. Still no update on dispute, Co-prep will be launched shortly along with RESplex and Hiberplex, R&D still pumping away but nothing to report yet"
I wouldn't expect them to RNS just for the sake of it but come on, 3 months and nothing on any of the developments we have going off. It's fair that shareholders are disgruntled and if they can't release that anger and frustration on here or to investor relations then where.